Avvinity Therapeutics

BiotechnologySeedLondon, UKavvinity.com

Latest round

Seed

Last raised

Sep 2020

Total raised

$3.9M

Investors

2

About Avvinity Therapeutics

Based in London ,UK, and established in 2016, Avvinity Therapeutics Limited was founded as an immuno-oncology joint venture between Horizon Discovery and Centauri Therapeutics. The biotechnology company develops novel immunotherapeutics for the treatment of cancer and solid tumours, including gastric cancer.

Who invested in Avvinity Therapeutics

2 investors across 1 round

See all investors in Avvinity Therapeutics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Seed

    Sep 23, 2020

    Amount

    $3.9M

    Investors

    Locked

Questions about Avvinity Therapeutics

Who invested in Avvinity Therapeutics?

Avvinity Therapeutics has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Avvinity Therapeutics raised?

Avvinity Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Avvinity Therapeutics last raise money?

Avvinity Therapeutics's most recent round on record is a Seed, in Sep 2020.

What does Avvinity Therapeutics do?

Based in London ,UK, and established in 2016, Avvinity Therapeutics Limited was founded as an immuno-oncology joint venture between Horizon Discovery and Centauri Therapeutics.

Where is Avvinity Therapeutics headquartered?

Avvinity Therapeutics is headquartered in London, UK.

Which VCs invest in companies like Avvinity Therapeutics?

Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at Avvinity Therapeutics's stage. Their profiles are linked below.

Raising like Avvinity Therapeutics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.